Fas ligand is expressed in normal skin and in some cutaneous malignancies
β Scribed by Lee; Jang; Lee; Kim; Park; Shin; Dong; NA; Kim; Kim; Kim; Yoo
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 401 KB
- Volume
- 139
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
β¦ Synopsis
Fas, a cell surface receptor and member of the tumour necrosis factor receptor superfamily, induces apoptosis upon oligomerization by its ligand (Fas ligand: FasL). Detailed studies have revealed that Fas is broadly expressed in normal human tissues, but relatively little is known about the range of cell types capable of expressing FasL. The aim of this study was to determine the in vivo patterns of expression of Fas and FasL in human skin tissues. Immunohistochemistry was performed using paraffin-embedded samples of normal and neoplastic skin tissues. In normal skin, FasL was expressed in the epidermis, sebaceous glands, sweat glands and outer root sheath of the hair. In squamous cell carcinomas (SCC), all cases analysed expressed FasL at high levels, whereas 60% of basal cell carcinomas (BCC) were positive for FasL. Expression of Fas in normal skin was observed in the basal and spinous layers of the epidermis, the outer root sheath of the hair, and the sebaceous glands. Expression of Fas was observed in all the SCC tested and none of the BCC tested. Expression of FasL by normal cells and tumour cells in skin tissue, demonstrated for the first time in the present study, may provide an important clue to understanding skin physiology, and immune evasion of skin tumours.
π SIMILAR VOLUMES
Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i
Fas (CD95/Apo-1) is a cell membrane receptor that upon binding by its ligand (FasL), triggers a signal resulting in apoptotic cell death. Fas is produced by breast epithelial cells, but its contribution to breast tissue homeostasis is unknown. This study investigated whether FasL is synthesized in t
## Abstract ## BACKGROUND Fas is a Type I membrane receptor of the tumor necrosis factor/nerve growth factor family. On binding to Fas ligand, a Type II transmembrane protein, the Fas/Fas ligand complex, induces apoptosis in target cells. Dysregulation of Fas and Fas ligand expression has been fou
## Background: Fas (cd95; apo-1) is a transmembrane protein that mediates apoptosis upon cross-linking with fas-ligand (fas-l). interaction of fas-l expressed by cytotoxic t cells with fas-expressing tumour cells plays an important part in antitumour immune responses. ## Objectives: We aimed to i